[Form 4] Confluent, Inc. Insider Trading Activity
Confluent, Inc. (CFLT) Chief Financial Officer Sivaram Rohan reported a sale of 5,000 shares of Class A common stock on 09/08/2025 at a price of $20.00 per share. The sale was made pursuant to a 10b5-1 trading plan dated September 12, 2024. After the reported transaction, the reporting person beneficially owned 631,596 shares of Class A common stock. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
- Sale executed under a 10b5-1 trading plan, indicating the transaction was prearranged and reduces concerns about opportunistic insider trading
- High retained ownership: the reporting person still beneficially owns 631,596 shares, showing continued significant stake
- None.
Insights
TL;DR: Routine insider sale under a prearranged plan; small transaction relative to total holdings, limited immediate market impact.
The 5,000-share sale executed at $20 per share was processed under a 10b5-1 plan, indicating it was pre-specified and not a discretionary trade. With 631,596 shares remaining beneficially owned, the transaction represents a small percentage of the reporting person’s stake and is unlikely to signal a change in insider conviction. For investors, this Form 4 documents compliance and transparency rather than new information about company fundamentals.
TL;DR: Disclosure aligns with governance best practices; use of 10b5-1 plan reduces regulatory and insider-trading concerns.
The filing clearly states the trade was made pursuant to a 10b5-1 trading plan, which is consistent with governance practices to avoid accusations of opportunistic insider trading. The Form 4 includes the requisite detail: transaction date, number of shares sold, price, and post-transaction beneficial ownership. The signature by an attorney-in-fact completes the reporting requirement. No governance red flags are evident from this single disclosure.